Philip Smith sells 30,000 SNEX shares (NASDAQ: SNEX)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
SNEX reported an insider sale of 30,000 shares by Philip Smith. The sale is listed with a transaction date of 04/10/2026 and identifies the class as Common stock. The filing also references earlier stock plan activity dated 12/15/2024.
Positive
- None.
Negative
- None.
Insights
Routine disclosure of an insider disposition; no broader corporate action shown.
The filing lists a 30,000-share sale by Philip Smith on 04/10/2026
Such Form 144 filings are procedural notifications of intended brokered sales under resale rules; the excerpt does not state proceeds, price, or whether sales were part of a pre-arranged plan.
Key Figures
Shares sold: 30,000 shares
Reported holding(?): 2,765,949
Stock plan activity date: 12/15/2024
3 metrics
Shares sold
30,000 shares
transaction date <date>04/10/2026</date>
Reported holding(?)
2,765,949
appears in the same line as the sale entry in the excerpt
Stock plan activity date
12/15/2024
listed under Securities To Be Sold as 'Stock plan activity'
Key Terms
Form 144, Stock plan activity, Issuer
3 terms
Form 144 regulatory
"Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock plan activity financial
"Securities To Be Sold | Common | 12/15/2024 | Stock plan activity"
Issuer regulatory
"Securities To Be Sold | ... | Issuer"
FAQ
What did SNEX's Form 144 disclose about Philip Smith's transactions?
It reports a sale of 30,000 common shares by Philip Smith on 04/10/2026. The form identifies the security as Common stock and shows a prior stock plan activity date of 12/15/2024 in the filing excerpt.
Who is the reporting person and what address is shown on the Form 144?
The reporting person is Philip Smith, with an address shown as 230 Park Ave, 10th Floor, New York, NY 10169 in the provided excerpt of the filing.